The AESOP Trial: A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of Obeticholic Acid in Patients with Primary Sclerosing Cholangitis

被引：0

作者：

Kowdley, Kris V. ^{[2
]}

Bowlus, Christopher L. ^{[3
]}

Levy, Cynthia ^{[4
]}

Vuppalanchi, Raj ^{[5
]}

Floreani, Annarosa ^{[6
]}

Andreone, Pietro ^{[7
]}

LaRusso, Nicholas F. ^{[8
]}

Shrestha, Roshan ^{[9
]}

Trotter, James ^{[1
]}

Goldberg, David S. ^{[10
]}

Rushbrook, Simon ^{[11
]}

Hirschfield, Gideon M. ^{[12
]}

Van Biene, Courtney ^{[13
]}

Pencek, Richard ^{[13
]}

MacConell, Leigh ^{[13
]}

Shapiro, David ^{[13
]}

机构：

[1] Baylor Univ, Div Transplant Hepatol, Dallas, TX USA

[2] Swedish Med Ctr, Seattle, WA USA

[3] Univ Calif Davis, Div Gastroenterol & Hepatol, Sacramento, CA 95817 USA

[4] Univ Miami, Miller Sch Med, Div Hepatol, Miami, FL 33136 USA

[5] Indiana Univ Sch Med, Indianapolis, IN 46202 USA

[6] Univ Padua, Padua, Italy

[7] Univ Bologna, Bologna, Italy

[8] Mayo Clin, Dept Med, Div Gastroenterol & Hepatol, Rochester, MN USA

[9] Piedmont Transplant Inst, Dept Transplantat, Atlanta, GA USA

[10] Univ Penn, Dept Med, Div Gastroenterol, Philadelphia, PA 19104 USA

[11] Norwich Med Sch, Fac Med & Hlth Sci, Norwich, Norfolk, England

[12] Univ Birmingham, Ctr Liver Res, NIHR BRU, Birmingham, W Midlands, England

[13] Intercept Pharmaceut Inc, San Diego, CA USA

来源：

HEPATOLOGY | 2017年 / 66卷 / 06期

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

LB-2

引用

页码：1254A / 1255A

页数：2

共 50 条

[21] Etanercept in Alzheimer disease: A randomized, placebo-controlled, double-blind, phase 2 trial
Butchart, Joseph
Brook, Laura
Hopkins, Vivienne
Teeling, Jessica
Puentener, Ursula
Culliford, David
Sharples, Richard
Sharif, Saif
McFarlane, Brady
Raybould, Rachel
Thomas, Rhodri
Passmore, Peter
Perry, V. Hugh
Holmes, Clive
NEUROLOGY, 2015, 84 (21) : 2161 - 2168
[22] A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF URSODEOXYCHOLIC ACID IN PRIMARY BILIARY-CIRRHOSIS
COMBES, B
CARITHERS, RL
MADDREY, WC
LIN, DY
MCDONALD, MF
WHEELER, DE
EIGENBRODT, EH
MUNOZ, SJ
RUBIN, R
GARCIATSAO, G
BONNER, GF
WEST, AB
BOYER, JL
LUKETIC, VA
SHIFFMAN, ML
MILLS, AS
PETERS, MG
WHITE, HM
ZETTERMAN, RW
ROSSI, SS
HOFMANN, AF
MARKIN, RS
HEPATOLOGY, 1995, 22 (03) : 759 - 766
[23] ETANERCEPT IN ALZHEIMER DISEASE: A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, PHASE 2 TRIAL
Tufan, Ayse N.
Tufan, Fatih
NEUROLOGY, 2015, 85 (23) : 2083 - 2084
[24] Control: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study Investigating the Effects of Obeticholic Acid and Atorvastatin Treatment on Lipoprotein Metabolism in Patients with Nonalcoholic Steatohepatitis
Pockros, Paul J.
Fuchs, Michael
Freilich, Bradley L.
Schiff, Eugene R.
Kohli, Anita
Lawitz, Eric J.
Hellstern, Paul A.
Cohen, David E.
Owens-Grillo, Janet
Van Biene, Courtney
Shringarpure, Reshma
MacConell, Leigh
Shapiro, David A.
HEPATOLOGY, 2018, 68 : 951A - 952A
[25] A PHASE 2b/3 RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND TRIAL FOR TREATMENT OF PRIMARY BILIARY CHOLANGITIS (PBC) WITH SETANAXIB: OBJECTIVES AND STUDY DESIGN
Jones, David
Carlsson, Stefan
Von Reedtz, Sari
Levy, Cynthia
HEPATOLOGY, 2022, 76 : S1461 - S1462
[26] A Randomized, Double-Blind, Placebo-Controlled Trial of Fluvoxamine in Patients With Schizophrenia A Preliminary Study
Niitsu, Tomihisa
Fujisaki, Mihisa
Shiina, Akihiro
Yoshida, Taisuke
Hasegawa, Tadashi
Kanahara, Nobuhisa
Hashimoto, Tasuku
Shiraishi, Tetsuya
Fukami, Goro
Nakazato, Michiko
Shirayama, Yukihiko
Hashimoto, Kenji
Iyo, Masaomi
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2012, 32 (05) : 593 - 601
[27] Applicability of Press Needles to a Double-blind Trial A Randomized, Double-blind, Placebo-controlled Trial
Miyazaki, Shougo
Hagihara, Akihito
Kanda, Ryo
Mukaino, Yoshito
Nobutomo, Koichi
CLINICAL JOURNAL OF PAIN, 2009, 25 (05): : 438 - 444
[28] Aprepitant in the Treatment of Subacute Sclerosing Panencephalitis: A Randomized, Double-Blind, Placebo-Controlled Study
Oncel, Ibrahim
Sancar, Mesut
Konuskan, Bahadir
Arioz, Filiz
Tezcan, Songul
Arman-Kandirmaz, Emine
Parlak, Safak
Gumeler, Ekim
Anlar, Banu
PEDIATRIC NEUROLOGY, 2020, 110 : 59 - 63
[29] EFFICACY AND SAFETY OF ELAFIBRANOR IN PRIMARY BILIARY CHOLANGITIS: RESULTS FROM THE ELATIVE™ DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED PHASE 3 TRIAL
Bowlus, Christopher L.
Kowdley, Kris V.
Levy, Cynthia
Akarca, Ulus
Alvares-Da-Silva, Mario Reis
Andreone, Pietro
Arrese, Marco
Corpechot, Christophe
Francque, Sven
Heneghan, Michael A.
Invernizzi, Pietro
Jones, David
Kruger, Frederik C.
Lawitz, Eric
Mayo, Marlyn J.
Shiffman, Mitchell L.
Swain, Mark G.
Valera, Jose Miguel
Vargas, Victor
Vierling, John M.
Villamil, Alejandra
Addy, Carol
Dietrich, Julie
Germain, Jean-Michel
Mazain, Sarah
Rafailovic, Dragutin
Tadde, Bachirou
Miller, Benjamin
Shu, Jianfen
Zein, Claudia O.
Schattenberg, Jorn M.
HEPATOLOGY, 2024, 79 (02) : E40 - E42
[30] A randomized double-blind placebo-controlled trial of thioctic acid in migraine prophylaxis
Magis, Delphine
Ambrosini, Anna
Sandor, Peter
Jacquy, Jean
Laloux, Patrice
Schoenen, Jean
HEADACHE, 2007, 47 (01): : 52 - 57

← 1 2 3 4 5 →